Adding stem cells to common bypass surgery may reduce heart failure

Apr 05, 2011

In a new research study under way at the Methodist DeBakey Heart & Vascular Center, surgeons are adding a patient’s own stem cells to the heart during cardiac bypass surgery. The goal of this research study is to determine whether the stem cell infusion will generate new blood vessels and improve heart function more than what is seen through bypass surgery alone.

"The injection of stem cells may improve the effectiveness of the bypass," said Dr. Brian Bruckner, cardiac surgeon and principle investigator on the research study. "We perform a bypass to reroute blood flow around blockages in the coronary arteries. The injection of stem cells might enhance the bypass surgery by causing the formation of new blood vessels at the site of injection."

In this study, stem cells are harvested from a subject’s own in the operating room while the research subject is under anesthesia. After the bone marrow cells are harvested, the surgeon then begins the bypass procedure. These cells are simultaneously processed to separate stem cells from bone marrow. After performing the bypass, the surgeon then injects the stem cells into the patient’s , and the procedure is complete.

The Methodist DeBakey Heart & Vascular Center is one of only three centers in the country to have this study available.

A potential benefit for study subjects is that the stem cells can be delivered during the bypass surgery, rather than needing an additional procedure," said Dr. Kevin Lisman, cardiologist at the Methodist DeBakey Heart & Vascular Center and co-investigator in the study. "To be considered for this trial, patients must have an existing need for heart and must have an ejection fraction of 40 percent or less. Up to 42 patients will be enrolled in this randomized study nationwide."

The research team cannot guarantee individual benefits from participating in the study.

The technology that processes the was developed by Harvest Technologies and it sorts the cells quickly, enabling the procedure to be interoperative, rather than having the patient come in days before surgery for the bone marrow aspiration.

Explore further: The impact of bacteria in our guts

Provided by Methodist Hospital System

3 /5 (1 vote)
add to favorites email to friend print save as pdf

Related Stories

Stem cells to be injected into the heart

Aug 26, 2005

The University of Pittsburgh Medical Center will begin a clinical trial to determine the feasibility of injecting a patient's own stem cells into the heart.

Stem cells to repair damaged heart muscle

Jun 22, 2007

In the first trial of its kind in the world, 60 patients who have recently suffered a major heart attack will be injected with selected stem cells from their own bone marrow during routine coronary bypass surgery.

How can you heal a broken heart?

Apr 12, 2010

Some patients with heart muscles seriously affected by coronary heart disease may soon be able to benefit from an innovative treatment. Researchers at the Research Centre of the Centre hospitalier de l'Université de ...

Recommended for you

The impact of bacteria in our guts

Aug 22, 2014

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

Aug 22, 2014

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

Aug 22, 2014

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

Aug 21, 2014

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments : 0